Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD
- Conditions
- Facioscapulohumeral Muscular Dystrophy 1a
- Interventions
- Other: No intervention, observational
- Registration Number
- NCT02541292
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy with approximately 500 patients in Denmark. It is characterized by weakness and wasting of the facial muscles, the muscles in the shoulder region and of the legs.
The primary aim of this study is to investigate possible links and order between inflammation and fat infiltration in the muscles in patients with FSHD.
Approximately 15 patients with FSHD will be recruited for repeated MRI-scans during a year where the inflammation and fat infiltration in the muscles can be quantified.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
- Confirmed FSHD
- All contraindications for undergoing an MRI scan
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patient group No intervention, observational Patients over 18 years old with confirmed FSHD (facioscapulohumeral muscular dystrophy).
- Primary Outcome Measures
Name Time Method Muscle inflammation One MRI scan per subject (exam lasts approximately 60 min.) MRI (t2 mapping) will be used to quantify the inflammation in skeletal muscle.
Muscle fat fraction One MRI scan per subject (exam lasts approximately 60 min.) The Dixon MRI will be used to quantify the fat fraction in skeletal muscle.
- Secondary Outcome Measures
Name Time Method Muscle strength One muscle strength test per subject (exam lasts approximately 60 min.) Isokinetic muscle dynamometry will be used to measure muscle strength.
Trial Locations
- Locations (1)
Copenhagen Neuromuscular Center
🇩🇰Copenhagen, Denmark